» Articles » PMID: 39717558

Editorial: Genomic Discoveries and Pharmaceutical Development in Urologic Tumors

Overview
Journal Front Pharmacol
Date 2024 Dec 24
PMID 39717558
Authors
Affiliations
Soon will be listed here.
References
1.
George S, Rini B, Hammers H . Emerging Role of Combination Immunotherapy in the First-line Treatment of Advanced Renal Cell Carcinoma: A Review. JAMA Oncol. 2018; 5(3):411-421. DOI: 10.1001/jamaoncol.2018.4604. View

2.
Morales A . From the 19th to the 21st centuries: BCG in the treatment of superficial bladder cancer. Eur Urol. 1992; 21 Suppl 2:2-6. DOI: 10.1159/000474913. View

3.
Dai C, Dehm S, Sharifi N . Targeting the Androgen Signaling Axis in Prostate Cancer. J Clin Oncol. 2023; 41(26):4267-4278. PMC: 10852396. DOI: 10.1200/JCO.23.00433. View

4.
Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R . Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024; 4(1):47-53. PMC: 11256708. DOI: 10.1016/j.jncc.2024.01.006. View

5.
Li R, Linscott J, Catto J, Daneshmand S, Faltas B, Kamat A . FGFR Inhibition in Urothelial Carcinoma. Eur Urol. 2024; 87(2):110-122. DOI: 10.1016/j.eururo.2024.09.012. View